BlackRock, Inc. (BLK) 13D/13G Filings for Flexion Therapeutics, Inc. (FLXN)

BlackRock, Inc. 13D and 13G filings for Flexion Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-01-29
09:57 am
Purchase
2020-12-31 13G Flexion Therapeutics, Inc.
FLXN
BlackRock Inc.
BLK
4,339,324
8.800%
1,274,672increase
(+41.59%)
Filing